Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors
2026年 1月 6日
Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference
2026年 1月 5日